Long term survival and outcomes in patients with paraneoplastic neurologic syndromes
In up to 8 years of follow up, there was no difference in mortality among patients who presented initially n-PNS. There was a significant decline in the quality of life, most face substantial disability and functional impairment long term.
Authors
- Nataliya Yarovinsky
- Esther Ganelin‐Cohen (ORCID: https://orcid.org/0000-0003-4802-5832)
- S Mucha (ORCID: https://orcid.org/0000-0001-6356-9083)
- Ayal Rozenberg
- Shahar Shelly (ORCID: https://orcid.org/0000-0002-3585-1687)
- Rachel Ben Hayun
- Alon Gorenshtein (ORCID: https://orcid.org/0009-0000-7542-8608)
- Lilach Gutter Kapon
Institutions
- Bar-Ilan University (IL)
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- Rambam Health Care Campus (IL)
- Schneider Children's Medical Center (IL)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-18
- DOI
- https://doi.org/10.3389/fimmu.2024.1466704
- Citations
- 5
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.85